Tecentriq SC (atezolizumab)

pCPA File Number: 22700
Negotiation Status:
Active Negotiation
Indication(s):
Multiple Indications
Sponsor/Manufacturer:
Hoffmann-La Roche Limited
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable